Through
4/26
Management
How to begin talking about race in the workplace
How to begin talking about race in the workplace
Wharton management professor Stephanie Creary explains her framework for middle managers in corporate environments who would like to initiate conversations about race in the workplace.
Working from home: Navigating the pandemic’s new normal
Working from home: Navigating the pandemic’s new normal
Wharton management professor discusses her research on how people navigate the boundaries between work and home, at a time when she is living her research in real life.
Confronting COVID-19: Why firms need to tap nonprofit partnerships
Confronting COVID-19: Why firms need to tap nonprofit partnerships
Wharton management professor Aline Gatignon argues that firms have an important role to play in the response to COVID-19, and should consider the unique ability of the nonprofit sector to serve hard-to-reach populations during disasters.
Wharton School launches a remote course on the impact and implications of COVID-19
Wharton School launches a remote course on the impact and implications of COVID-19
Starting March 25, the new course will address in real time how global business and financial uncertainty can be managed in the wake of such dramatic events.
Why don’t women promote themselves?
Why don’t women promote themselves?
Wharton’s Judd Kessler co-authored a study, “The Gender Gap in Self-Promotion,” which measured confidence and self-promotion among women about their performance at work.
The state of the auto industry in the 2020s
The state of the auto industry in the 2020s
The Wharton School’s Professor of Management John Paul MacDuffie names current trends in the auto industry and where it’s headed in the future.
The confidence gap between men and women
The confidence gap between men and women
When employers are looking at self-performance reviews, they are more likely to hire those who rate themselves higher—men.
Self-awareness is the key to more effective team discussions
Self-awareness is the key to more effective team discussions
Wharton’s Barbara Mellers and doctoral student Ike Silver discuss their research on “collective confidence calibration” and the effectiveness of team discussions.
How companies like the NBA could benefit from ‘corporate diplomacy’
How companies like the NBA could benefit from ‘corporate diplomacy’
In a Q&A, Professor of Manaement Witold Henisz explains how recent controversies involving the NBA and Activision-Blizzard can be prevented through increased focus on corporate diplomacy.
The key to keeping your employees happy
The key to keeping your employees happy
Moods, emotions, even smiles are some of the emotional contagions Wharton professor Sigal Barsade cites as what are passed along throughout the workplace, making the professional environment either more pleasant or more unhappy.
In the News
BBC
Boycotts aren’t the only way to hold companies accountable
Maurice Schweitzer of the Wharton School says that calls to boycott companies are complicated by the sister brands and different platforms of large corporations.
FULL STORY →
WHYY (Philadelphia)
Should you be friends with your coworkers?, update from the polls, jazz trumpet player Terell Stafford
Nancy Rothbard of the Wharton School explains how to manage the upsides and downsides of workplace friendships.
FULL STORY →
The New Yorker
How to die in good health
PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one.
FULL STORY →
WHYY (Philadelphia)
Bridging Blocks has Philadelphians focused on dispelling myths around immigration
Exequiel Hernandez of the Wharton School says that immigrants are net positive contributors to everything that makes a community prosperous.
FULL STORY →
Yahoo! Finance
AI will change work, for better and worse
Sonny Tambe of the Wharton School says that AI is a useful tool for most people, not an existential threat.
FULL STORY →
Associated Press
Many cancer drugs remain unproven five years after accelerated approval, a study finds
PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval.
FULL STORY →